Can a 25 mg metoprolol succinate extended-release tablet be split into four pieces?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 3, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Do Not Cut Metoprolol Succinate 25mg Into Four Pieces

Metoprolol succinate extended-release tablets should not be cut into four pieces. While the FDA-approved labeling states these tablets are scored and can be divided in half, cutting them into quarters (four pieces) is not recommended and will likely result in significant dose inaccuracy and loss of the extended-release properties 1.

Why Splitting Into Quarters Is Problematic

Loss of Extended-Release Mechanism

Metoprolol succinate tablets contain multiple controlled-release pellets designed to deliver medication continuously over 24 hours 2. Each pellet functions as an independent drug delivery unit. When you cut the tablet:

  • Halving is acceptable because the tablet is specifically scored for this purpose and maintains enough pellet distribution 1
  • Quartering destroys the formulation integrity by creating pieces too small to contain adequate pellet distribution, resulting in unpredictable drug release

Dose Inaccuracy With Multiple Cuts

Research demonstrates significant problems with tablet splitting accuracy:

  • When metoprolol succinate 200mg tablets were split in half, 33.3% of half-tablets fell outside acceptable drug content ranges 3
  • The relative standard deviation for drug content was 8.98%, exceeding acceptable limits 3
  • Non-homogeneous distribution of pellets on tablet surfaces explains large variations in split tablet weight and content 2
  • Quartering would exponentially worsen these accuracy problems

Mass Loss and Fragmentation

  • Tablets lose powder and fragments during splitting, with metoprolol succinate showing significant weight variability 3
  • Multiple cuts (to create quarters) would result in greater mass loss and more fragmentation
  • Average weight loss can exceed 1% even with single splits 3

What You Should Do Instead

If 6.25mg Dosing Is Needed

  • Request a prescription for the appropriate strength rather than quartering tablets
  • The FDA labeling specifies initial doses of 12.5mg or 25mg for heart failure patients 1
  • If 6.25mg is truly required, consider metoprolol tartrate immediate-release formulation, which comes in smaller doses and can be split more reliably

Acceptable Splitting Practice

  • Only split metoprolol succinate tablets in HALF along the score line 1
  • Use a tablet splitter device rather than hand-splitting for better accuracy 3, 4
  • Swallow the whole or half tablet without chewing or crushing 1

Clinical Monitoring

If you must use split tablets:

  • Monitor for signs of inadequate beta-blockade (elevated heart rate, blood pressure)
  • Watch for excessive beta-blockade (bradycardia, hypotension, heart failure exacerbation)
  • Consider checking heart rate and blood pressure more frequently during dose titration

Important Caveat

The evidence consistently shows that sustained-release formulations should not be split when it alters the rate of drug release 5. While metoprolol succinate tablets are FDA-approved for splitting in half due to their scored design, this approval does not extend to quartering. The pellet-based extended-release system makes accurate quartering essentially impossible while maintaining therapeutic efficacy.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.